Precigen: Summary

Precigen

Biopharmaceutical, gene therapy, cell therapy, precision medicine

Precigen offers innovative biotherapeutics that target urgent and intractable diseases with improved safety and efficacy.

Precigen is a biopharmaceutical company focused on advancing gene and cell therapies. It aims to provide innovative solutions for urgent diseases through precision technology.

Next-generation gene and cell therapies; Non-viral and viral expression systems; Precision bioengineering switch technologies; Focus on immuno-oncology, autoimmune disorders, and infectious diseases

Treatment of recurrent respiratory papillomatosis; Therapies for cancer patients; Addressing autoimmune disorders; Developing solutions for infectious diseases

Strong focus on precision technology for targeted therapies; A comprehensive pipeline of unique therapies; Commitment to affordability and accessibility of biotherapeutics

Precigen's strengths lie in its innovative approach to therapy development, a robust pipeline, and a commitment to addressing critical health challenges.

Precigen positions itself as a leader in the biopharmaceutical industry, focusing on precision medicine to tackle the most pressing health issues.

The primary audience includes healthcare professionals, researchers in biopharmaceuticals, patients with urgent health needs, and potential investors.

Join our team

• gene therapy

• cell therapy

• biopharmaceuticals

• precision medicine

Advancing Medicine with Precision®

Innovative, urgent, dedicated

Precigen differentiates itself by utilizing a disciplined design approach that combines various advanced technologies to deliver potent therapies.

The brand is identified as an innovative and dedicated player in the life sciences sector, committed to advancing medicine through precision technologies.

1998-01-01

• Thomas D. Reed